Please use this identifier to cite or link to this item:
https://ahro.austin.org.au/austinjspui/handle/1/31626| Title: | Hyperoxemia in invasively ventilated COVID-19 patients-Insights from the PRoVENT-COVID study. | Austin Authors: | Tsonas, A M;van Meenen, D M;Botta, M;Shrestha, G S;Roca, O;Paulus, F;Serpa Neto, Ary ;Schultz, M J | Affiliation: | Department of Intensive Care, Amsterdam UMC, location 'AMC', Amsterdam, The Netherlands; Australian and New Zealand Intensive Care Research Centre (ANZIC-RC), Monash University, Melbourne, Australia Department of Intensive Care, Amsterdam UMC, location 'AMC', Amsterdam, The Netherlands. Data Analytics Research and Evaluation (DARE) Centre Department of Critical Care Medicine, Hospital Israelita Albert Einstein, Sao Paulo, Brazil. Department of Intensive Care, Amsterdam UMC, location 'AMC', Amsterdam, The Netherlands. Department of Critical Care Medicine, Tribhuvan University Teaching Hospital, Maharajgunj, Kathmandu, Nepal. Department of Intensive Care, Vall d'Hebron Univerity Hospital, Barcelona, Spain; Ciber Enfermedades Respiratorias (CibeRes), Instituto de Salud Carlos III, Madrid, Spain. |
Issue Date: | 15-Sep-2022 | Date: | 2022 | Publication information: | Pulmonology 2022 | Abstract: | We determined the prevalences of hyperoxemia and excessive oxygen use, and the epidemiology, ventilation characteristics and outcomes associated with hyperoxemia in invasively ventilated patients with coronavirus disease 2019 (COVID-19). | URI: | https://ahro.austin.org.au/austinjspui/handle/1/31626 | DOI: | 10.1016/j.pulmoe.2022.09.003 | ORCID: | Journal: | Pulmonology | PubMed URL: | 36274046 | ISSN: | 2531-0437 | Type: | Journal Article | Subjects: | ARDS COVID–19 Coronavirus disease 2019 Hyperoxemia Invasive ventilation Mortality Normoxemia Oxygen management Ventilation |
| Appears in Collections: | Journal articles |
Show full item record
Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.